Inactive Instrument

Company Nuo Therapeutics Inc OTC Bulletin Board

Equities

Biotechnology & Medical Research

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for Nuo Therapeutics Inc

Business Summary

Nuo Therapeutics, Inc. is a commercial stage medical device company. The Company is focused on developing and marketing products for chronic wound care primarily within the United States. The Company commercializes cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The Company's product, Aurix, is a biodynamic hematogel that uses a patient's own platelets and plasma as a catalyst for healing. Its commercial offering consists of point of care technology for the separation of autologous blood to produce a platelet-based therapy for the chronic wound care market. This offering is known as Aurix or the Aurix System. The Aurix System produces a platelet rich plasma (PRP) gel at the point of care using the patient's own platelets and plasma sourced from a small draw of peripheral blood. Aurix comprises a natural, endogenous complement of protein and non-protein signal molecules that contribute to effective healing.

Sales per Business

USD in Million2022Weight2023Weight Delta
Innovative Cell-based Technologies
100.0 %
0 100.0 % 1 100.0 % +442.12%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
0 100.0 % 1 100.0 % +442.12%

Managers

Managers TitleAgeSince
Chief Executive Officer 61 19/08/19
Chief Operating Officer 58 01/08/01

Members of the board

Members of the board TitleAgeSince
Director/Board Member 67 30/09/30
Chief Executive Officer 61 19/08/19
Director/Board Member 75 07/17/07
Director/Board Member 65 05/16/05

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 45,466,238 18,981,995 ( 41.75 %) 0 41.75 %

Shareholders

NameEquities%Valuation
11,315,865 25.58 % 8 M $
5,178,345 11.70 % 4 M $
Boyalife Investment Fund I, Inc.
11.08 %
4,900,000 11.08 % 4 M $
Paul Anthony & Nancy E. Jacobs Joint Trust
5.651 %
2,500,000 5.651 % 2 M $
Deerfield Management Co. LP
4.935 %
2,183,164 4.935 % 2 M $
1,975,358 4.465 % 1 M $
589,675 1.333 % 442 256 $
C. Winzer
0.0565 %
25,000 0.0565 % 18 750 $
Ancora Family Wealth Advisors LLC
0.0106 %
4,700 0.0106 % 3 525 $
Paul Mintz
0.000000 %
0 0.000000 % - $

Company contact information

Nuo Therapeutics, Inc.

8285 El Rio Suite 190

77054, Houston

+346 396 4770

http://www.nuot.com
address Nuo Therapeutics Inc
  1. Stock Market
  2. Equities
  3. AURX Stock
  4. Stock
  5. Company Nuo Therapeutics Inc